Listed

Maximus, Inc.: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on May 9, 2014 and accepted by EDGAR at May 9, 2014, 12:04 ET.

Share

Management's discussion and analysis

As filed, 29,489 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2013, filed with the Securities and Exchange Commission on November 19, 2013.

Business Overview

We provide business process services (BPS) to government health and human services agencies under our mission of Helping Government Serve the People. ® Our business is focused almost exclusively on administering government-sponsored programs, such as Medicaid, CHIP, health care reform, welfare-to-work, Medicare, child support and other government programs. We are one of the largest pure-play health and human services administrative providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. We use our deep domain expertise, repeatable processes and technology solutions to help government agencies run efficient, cost-effective programs and to improve program accountability and outcomes, while enhancing the quality of services provided to program beneficiaries.

Both within the United States and internationally, governments are being challenged by factors that increase social burdens, including aging populations and demands for health care reform, offset by reduced funds with which to deal with these demands. We believe that these trends will continue to provide a demand for services that can be met by companies such as MAXIMUS. We are also seeing increased scrutiny and heightened accountability within the markets which we serve. The Company believes that a combination of its rigorous employee training, stringent adherence to its Standards of Business Conduct and Ethics, robust financial performance and global experience gives existing and future customers the confidence that MAXIMUS can reliably operate their high-profile public health and human services programs.

Financial overview

The Company experienced significant growth in both revenue and operating profit for the three and six month periods ended March 31, 2014 compared to the same periods in fiscal year 2013. The principal driver of this growth was work in our Health Services segment related to the Affordable Care Act (ACA). In serving our clients, we delivered high-quality customer contact center operations and comprehensive contingency plans where technology issues in the health insurance exchanges were causing delays. The Company was also effectively able to address spikes in call volumes where consumers were unable to enroll in health plans using health insurance exchange websites.

The Company continues to see opportunities to expand further our business related to the ACA and Medicaid-related initiatives. MAXIMUS is currently providing customer contact centers for five states, the District of Columbia and the United States Federal Government. The Company anticipates that some states currently utilizing the federal marketplace may migrate to their own exchanges over the next several years. If this does occur, there will be opportunities for experienced service providers such as MAXIMUS to operate these exchanges.

The Company reported strong operating cash flows in the six month period ended March 31, 2014 driven by increased business. The Company continued to invest funds in working capital as well as in repurchases of common stock. At March 31, 2014, the Company held $131.3 million in unrestricted cash and cash equivalents and had minimal debt.

Results of Operations

Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

(dollars in thousands, except per share data)

Three Months Ended March 31, 2014 2013 Six Months Ended March 31, 2014 2013
Revenue $439,015 $326,351 $845,607 $612,617
Gross profit $120,672 $97,444 $226,588 $173,974
Gross profit percentage 27.5% 29.9% 26.8% 28.4%
Selling, general and administrative expenses $55,129 $46,693 $107,732 $88,915
Selling, general and administrative expense as a percentage of revenue 12.6% 14.3% 12.7% 14.5%
Acquisition-related expenses — 16 — 164
Legal and settlement expenses 600 — 600 142
Operating income from continuing operations $64,943 $50,735 $118,256 $84,753
Operating margin from continuing operations percentage 14.8% 15.5% 14.0% 13.8%
Interest and other income, net 183 637 904 1,743
Income from continuing operations before income taxes 65,126 51,372 119,160 86,496
Provision for income taxes 23,964 19,658 44,198 32,999
Tax rate 36.8% 38.3% 37.1% 38.2%
Income from continuing operations, net of income taxes $41,162 $31,714 $74,962 $53,497
Income (loss) from discontinued operations, net of income taxes $45 $(25) $104 $(492)
Net income $41,207 $31,689 $75,066 $53,005
Basic earnings (loss) per share:
Income from continuing operations $0.61 $0.47 $1.10 $0.78
Income (loss) from discontinued operations — (0.01) — —
Basic earnings per share $0.61 $0.46 $1.10 $0.78
Diluted earnings (loss) per share:
Income from continuing operations $0.59 $0.45 $1.08 $0.77
Income (loss) from discontinued operations — — — (0.01)
Diluted earnings per share $0.59 $0.45 $1.08 $0.76

The following provides an overview of the significant elements of our Consolidated Statements of Operations. As each of our business segments have different factors driving revenue growth and profitability, the sections that follow cover these segments in greater detail.

The results for the three and six month periods ended March 31, 2013 were affected by a one-time benefit from the termination of a system-integration contract acquired with Policy Studies Inc. (PSI). This termination resulted in one-time, non-cash benefits to revenue and pre-tax profit of $16.0 million and $10.9 million, respectively. Although contract terminations for convenience do occur within our business, they are infrequent. In addition, this termination was unusual due to the significant effect of the transaction, which is highly unlikely to be repeated, as it involved deferred revenue from the PSI acquisition and did not reflect the underlying business operations of the Company. Accordingly, we discuss below the results of the business both including and excluding the effect of this contract termination. We believe the presentation of revenue, profit, profit margins and earnings per share excluding the effect of this contract termination provide a useful basis for assessing the Company’s performance compared to prior periods or our competitors. However, these numbers are “non-GAAP” numbers and are not meant to be considered in isolation or as alternatives to their GAAP equivalents as measures of performance. A reconciliation between the Company’s results and those results excluding the effect of this terminated contract is shown below:

(dollars in thousands)

Three Months Ended March 31, 2013 Six Months Ended March 31, 2013
Revenue $326,351 $612,617
Less revenue from terminated contract (16,035) (16,035)
Revenue excluding terminated contract $310,316 $596,582
Gross profit $97,444 $173,974
Less gross profit from terminated contract (10,900) (10,900)
Gross profit excluding terminated contract $86,544 $163,074
Operating income $50,735 $84,753
Less operating income from terminated contract (10,900) (10,900)
Operating income excluding terminated contract 39,835 73,853
Gross profit margin excluding terminated contract 27.9% 27.3%
Operating margin percentage excluding terminated contract 12.8% 12.4%

We discuss constant currency revenue information to provide a framework for assessing how our business performed excluding the effect of foreign currency rate fluctuations. Constant currency revenue growth is a non-GAAP number that we believe is useful for assessing the performance of the business excluding the effects of currency fluctuations. To provide this information, revenue from foreign operations is converted into United States dollars using exchange rates from the comparative period in the prior fiscal year. Constant currency revenue growth should not be considered in isolation, nor as an alternative to revenue growth. In addition, this non-GAAP financial measure, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

In assessing the performance of our business, we believe that it is helpful to our investors to show organic revenue growth, which represents the increase in revenue from contracts excluding those acquired in business combinations within the last twelve months. Organic growth is a non-GAAP number that we believe provides a useful basis for assessing the performance of the business excluding the results of acquisitions. In order to calculate organic growth, we remove the revenue from HML from the three and six month periods ended March 31, 2014. Organic growth is not meant to be used in isolation, nor as an alternative to revenue growth as a measure of performance. In addition, this non-GAAP financial measure, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies. In January 2014, the Company acquired additional business in Australia, which would typically be excluded from our organic growth calculation. However, as the contracts acquired with the acquisition were immediately integrated into existing, identical contracts held by MAXIMUS, we are unable to accurately estimate the revenue from this acquisition. However, we believe the acquired revenue from this acquisition would not be material to the business or to the analyses shown below.

Revenue growth for the three and six months ended March 31, 2014 is summarized below:

(dollars in thousands)

Three Months Ended March 31 Six Months Ended March 31
Revenue for fiscal year 2013, respective periods $326,351 $612,617
Revenue from terminated contract (16,035) (5)% (16,035) (3)%
Revenue for fiscal year 2013, respective periods, excluding terminated contract $310,316 $596,582
Organic growth 112,654 35% 218,453 36%
Acquired growth 16,045 5% 30,572 5%
Revenue for fiscal year 2014, respective periods $439,015 35% $845,607 38%

15

Revenue increased 35% and 38% for the three and six month periods ended March 31, 2014, compared to their respective comparative periods. This growth was principally driven by organic growth in the Health Services Segment. The Company also received the benefit of the acquisition of HML, which increased revenue by approximately 5% compared to prior year, offset by the effect of the terminated contract. On a constant currency basis, overall revenue growth would have been 37% and 40% for the three and six month periods ended March 31, 2014, respectively. A decline in the value of the Australian Dollar was responsible for much of the shortfall in revenue.

Gross profit margin declined from 29.9% to 27.5% for the three month period ended March 31, 2014 and declined from 28.4% to 26.8% for the six month period ended March 31, 2014, compared to the same periods in fiscal year 2013. The principal cause of this decline is the termination of the contract noted above.

Selling, general and administrative expense (SG&A) consists of costs related to general management, marketing and administration. These costs include salaries, benefits, bid and proposal efforts, travel, recruiting, continuing education, employee training, non-chargeable labor costs, facilities costs, printing, reproduction, communications, equipment depreciation, intangible amortization and legal expenses incurred in the ordinary course of business. SG&A as a percentage of revenue has declined in the quarter ended March 31, 2014, compared with the same period in the prior year. This decline was driven by the significant increase in revenue in fiscal year 2014.

Operating income for the three and six month periods ended March 31, 2014 increased 28% to $64.9 million and 40% to $118.3 million, compared with the comparative periods in fiscal year 2013. If the effect of the contract termination noted above is excluded, operating income growth would have been 63% and 60%, respectively. This growth was driven by organic growth and the acquisition of HML.

Interest and other income, net includes interest earned on cash and cash equivalents and on a note received by the Company for the disposal of a business in fiscal year 2008. The balance also includes immaterial foreign exchange gains and losses and the noncontrolling interest of our operations. Almost all of the income recorded represents income from interest on cash accounts in overseas jurisdictions. The declines recorded reflect the use of overseas cash balances in July 2013 to acquire HML.

The provision for income taxes in the three and six months ended March 31, 2014 was $24.0 million and $44.2 million, respectively, reflecting effective tax rates of 36.8% and 37.1%, respectively. The tax rates are lower than the comparative periods as the Company received the benefit of certain tax credits in this period totaling approximately $0.7 million.

Income from continuing operations, net of income taxes, was $41.2 million, or $0.59 per diluted share, for the three months ended March 31, 2013, compared with $31.7 million, or $0.45 per diluted share, for the same period in fiscal year 2013. For the six month periods ended March 31, 2014 and 2013, income from continuing operations, net of income taxes, was $75.0 million and $53.5 million, or $1.08 and $0.77 per diluted share, respectively. For the periods ending March 31, 2013, net income and diluted earnings per share included the one-time benefits of $6.5 million and $0.09, respectively, from the contract termination noted above.

Health Services

The Health Services Segment provides a variety of business process services for state, provincial and federal programs, such as the ACA, Medicaid, CHIP, Medicare and the Health Insurance British Columbia Program.

(dollars in thousands)

Three Months Ended March 31, 2014 2013 Six Months Ended March 31, 2014 2013
Revenue $324,060 $197,948 $623,218 $373,946
Gross profit 85,061 54,651 161,879 99,910
Operating income 48,776 28,909 90,329 49,535
Gross profit percentage 26.2% 27.6% 26.0% 26.7%
Operating margin percentage 15.1% 14.6% 14.5% 13.2%

Revenue increased by 64% and 67% for the three and six month periods ended March 31, 2014, compared with the comparative periods in fiscal year 2013. Organic revenue provided the majority of this growth, being 56% and 58% of the increase, respectively, with the balance made up of HML revenues. Increases in revenue were driven by:

  • Revenues from new work and expansion of existing contracts, including those related to the implementation and support of the ACA;
  • Increased volumes in our appeals and assessments businesses, which is reimbursed on a per-transaction basis; and
  • The acquisition of HML in July 2013.

We anticipate that increased demand for ACA and Medicaid-related services will continue throughout fiscal year 2014 with additional supplemental work to support both programs. We anticipate that volumes within our appeals and assessments businesses will continue to remain strong as new appeals and assessments work offsets a slow-down, expected in fiscal year 2015, in Medicare appeals volumes due to changes in the Recovery Audit Contractor (RAC) program. Future demand may fluctuate either up or down on a seasonal basis or in future enrollment years.

Gross profit margins for the three and six months ended March 31, 2014 were slightly lower than those in the same periods in fiscal year 2013. Gross profit margins remain consistent with prior periods and Company expectations; although short-term fluctuations may be driven by the timing of change orders, open enrollments and the contract lifecycle, these changes are not expected to be significant. Operating profit margin has improved compared to fiscal year 2013, driven by the significant increase in business.

Human Services

The Human Services Segment includes a variety of business process services, case management, job training and support services for programs such as welfare-to-work programs, child support, K-12 special education and other specialized consulting services.

(dollars in thousands)

Three Months Ended March 31, 2014 2013 Six Months Ended March 31, 2014 2013
Revenue $114,955 $128,403 $222,389 $238,671
Gross profit 35,611 42,793 64,709 74,064
Operating income 16,767 21,459 28,527 35,141
Gross profit percentage 31.0% 33.3% 29.1% 31.0%
Operating margin percentage 14.6% 16.7% 12.8% 14.7%

The results in fiscal year 2013 were significantly affected by the terminated contract, the effects of which are summarized below:

(dollars in thousands)

Three Months Ended March 31, 2013 Six Months Ended March 31, 2013
Revenue $128,403 $238,671
Less revenue from terminated contract (16,035) (16,035)
Revenue excluding terminated contract $112,368 $222,636
Gross profit $42,793 $74,064
Less gross profit from terminated contract (10,900) (10,900)
Gross profit excluding terminated contract 31,893 63,164
Operating income $21,459 $35,141
Less operating income from terminated contract (10,900) (10,900)
Operating income excluding terminated contract $10,559 $24,241
Gross profit margin percentage excluding terminated contract 28.4% 28.4%
Operating margin percentage excluding terminated contract 9.4% 10.9%

Revenues decreased 10% and 7% for the three and six month periods ended March 31, 2014, compared to the comparative periods in fiscal 2013. Excluding the effects of the terminated contract, revenues increased 2% and remained consistent over the same periods. On a constant currency basis and excluding the terminated contract, revenues would have increased 7% and 4% for the three and six month periods, respectively.

Gross and operating profit margins have declined year-over-year, driven by the terminated contract. Excluding this effect, profit margins have increased, driven by expected increases for the quarter in international business and short-term consulting contracts.

In future quarters, we anticipate additional growth from the expansion of our contracts in Australia, where MAXIMUS has been awarded a greater allocation of work based upon past performance. Much of this work is expected to commence in the final quarter of fiscal year 2014.

Discontinued operations

The Company continues to record small gains on the sale of Unison MAXIMUS, Inc. (“Unison”), a business that was sold in May 2008. The consideration for the sale included a promissory note that is fully reserved. Small payments continue to be received on this note but owing to uncertainties over the collectability of the full balance, the Company has only recorded a gain on sale where recovery is considered assured, which is typically when cash payments are received. The Company has recorded gains of $0.2 million in the six month periods ended March 31, 2014 and 2013.

Liquidity and Capital Resources

At March 31, 2014, the Company held $131.3 million in cash and cash equivalents. Approximately 65% of these funds are held in overseas locations in which we do business, principally Australia, Canada and the United Kingdom. If we were to transfer these funds to the United States, the Company would be required to accrue and pay additional taxes. We do not intend to repatriate these funds and, accordingly, we have not attempted to quantify the charges which might arise if we were to make this transaction. The charges would vary based upon tax legislation in the United States and the other overseas jurisdictions, as well as the manner and timing in which MAXIMUS would make these transactions.

Owing to restrictions in transferring funds to the United States, domestic cash flows are required to cover dividend payments and share repurchases. In addition, the acquisition of PSI was funded with domestic cash and we would expect any other acquisitions taking place in the United States would be funded in a similar manner. Payments from our customers are our principal source of cash inflows, which are affected by billing schedules, payment terms and delays in payments. Delays in payments most often occur at the beginning of contractual arrangements or may be driven by difficulties with state and local budgets. Although the Company has experienced such delays from customers, most funds are ultimately recovered in full. The Company may also experience cash outflows from contracts at their inception, as start-up costs are incurred prior to revenues being billable, and, where contracts are performance-based, a project may experience initial cash outflows until outcome-based payments are received. To provide against such outflows, the Company utilizes a credit facility with up to $100 million of borrowing capacity. During the three month period ended March 31, 2014, the Company borrowed $15 million to cover short-term cash requirements. This balance was repaid within the quarter and no such borrowings were outstanding at March 31, 2014. The only indebtedness under this credit facility at March 31, 2014 relates to four letters of credit totaling $6.7 million. In addition, the Company has two letters of credit totaling $3.0 million outstanding with another financial institution.

In general, although some overseas locations have required initial investment, the Company has been able to utilize cash flows from operations to fund working capital and capital expenditure requirements in all locations in which it has operated and the Company continues to expect that this will be the case. The Company has one overseas loan: an interest-free loan from the Atlantic Innovation Fund of Canada, which must be used for specific purposes.

At March 31, 2014, the Company was in compliance with all debt covenants.

Cash Flows

(dollars in thousands)

Net cash provided by (used in): Six Months Ended March 31, 2014 2013
Operating activities — continuing operations $76,564 $39,494
Operating activities — discontinued operations (104) (554)
Investing activities — continuing operations (19,349) (18,039)
Financing activities — continuing operations (50,378) (21,866)
Effect of exchange rate changes on cash and cash equivalents (1,027) (1,004)
Net increase (decrease) in cash and cash equivalents $5,706 $(1,969)

18

Cash provided by operating activities from continuing operations for the six months ended March 31, 2014 was $76.6 million, compared with $39.5 million in the same period in fiscal year 2013. This increase is driven by the Company’s increased profitability.

Cash used in investing activities from continuing operations for the six months ended March 31, 2014 was $19.3 million, compared to $18.0 million for the same period in fiscal year 2013. Investment in property and equipment and capitalized software has declined by approximately $4.8 million year-over-year, reflecting the significant investment which occurred in fiscal year 2013 to address many project start-ups in fiscal year 2014. This decline was offset by a payment of $2.7 million in fiscal year 2014 related to the Company’s acquisition of Centacare’s business and the receipt of $3.4 million in fiscal 2013 related to the final settlement of the acquisition price of PSI.

Cash used in financing activities from continuing operations for the six months ended March 31, 2014 was $50.4 million, compared to $21.9 million for the same period in fiscal year 2013. The principal driver of the increase was an increase of $19.3 million for share repurchases of common stock.

The Company’s cash balance decreased by $1.0 million in the six-month period ended March 31, 2014 owing to foreign exchange rate fluctuations. The principal driver of this change was the weakening of the Canadian Dollar against the United States Dollar.

To supplement our statements of cash flows presented on a GAAP basis, we use the non-GAAP measure of free cash flow from continuing operations to analyze the funds generated from operations. We believe free cash flow from continuing operations is a useful basis for comparing our performance with our competitors. The presentation of non-GAAP free cash flows from continuing operations is not meant to be considered in isolation, or as an alternative to net income as an indicator of performance, or as an alternative to cash flows from operating activities as a measure of liquidity. We calculate free cash flow from continuing operations as follows:

(dollars in thousands)

Six Months Ended March 31, 2014 2013
Cash provided by operating activities — continuing operations $76,564 $39,494
Purchases of property and equipment (9,516) (13,351)
Capitalized software costs (7,317) (8,240)
Free cash flow from continuing operations $59,731 $17,903

Repurchases of the Company’s common stock

Under a resolution adopted in November 2011, the Board of Directors authorized the repurchase, at management’s discretion, of up to an aggregate of $125.0 million of the Company’s common stock. The resolution also authorized the use of option exercise proceeds for the repurchase of the Company’s common stock. During the six months ended March 31, 2014 and 2013, the Company repurchased 807,138 and 499,098 common shares at a cost of $35.5 million and $14.6 million, respectively. The amount available for future repurchases was $62.1 million at March 31, 2014.

Letters of Credit and Performance Bonds

Certain contracts require us to provide a letter of credit or a surety bond as a guarantee of performance. At March 31, 2014, the Company had letters of credit totaling $9.7 million and performance bond commitments totaling $50.5 million. These letters of credit and performance bonds are typically renewed annually and remain in place until the contractual obligations have been satisfied. Although the triggering events vary from contract to contract, in general, we would only be liable for the amount of these guarantees in the event of default in our performance of our obligations under each contract, the probability of which we believe is remote.

Dividend

On April 4, 2014, the Company’s Board of Directors declared a quarterly cash dividend of $0.045 for each share of the Company’s common stock outstanding. The dividend is payable on May 30, 2014 to shareholders of record on May 15, 2014.

Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expenses. On an ongoing basis, we evaluate our estimates including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill, and amounts related to income taxes, certain accrued liabilities and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

We believe that we do not have material off-balance-sheet risk or exposure to liabilities that are not recorded or disclosed in our financial statements. While we have significant operating lease commitments for office space, those commitments are generally tied to the period of performance under related contracts. Additionally, although on certain contracts we are bound by performance bond commitments and standby letters of credit, we have not had any defaults resulting in draws on performance bonds. Also, we do not speculate in derivative transactions.

During the three months ended March 31, 2014, there were no significant changes to the critical accounting policies we disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended September 30, 2013.

Market risk

As filed, 407 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We believe that our exposure to market risk related to the effect of changes in interest rates, foreign currency exchange rates, commodity prices and other market risks with regard to instruments entered into for trading or for other purposes is immaterial.

There have been no material changes in the information presented in Item 7A of our Annual Report on Form 10-K for the year ended September 30, 2013.

Controls and procedures

As filed, 1,546 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 396 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2013 should be considered. The risks included in the Form 10-K could materially and adversely affect our business, financial condition and results of operations. There have been no material changes to the factors discussed in our Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-01-01 to 2014-03-31$439.0mus-gaap:Revenues
Revenue6 months2013-10-01 to 2014-03-31$845.6mus-gaap:Revenues
Cost of revenue3 months2014-01-01 to 2014-03-31$318.3mus-gaap:CostOfRevenue
Cost of revenue6 months2013-10-01 to 2014-03-31$619.0mus-gaap:CostOfRevenue
Gross profit3 months2014-01-01 to 2014-03-31$120.7mus-gaap:GrossProfit
Gross profit6 months2013-10-01 to 2014-03-31$226.6mus-gaap:GrossProfit
Selling, general and administrative3 months2014-01-01 to 2014-03-31$55.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2013-10-01 to 2014-03-31$107.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-01-01 to 2014-03-31$64.9mus-gaap:OperatingIncomeLoss
Operating income6 months2013-10-01 to 2014-03-31$118.3mus-gaap:OperatingIncomeLoss
Income tax3 months2014-01-01 to 2014-03-31$24.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2013-10-01 to 2014-03-31$44.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-01-01 to 2014-03-31$41.2mus-gaap:NetIncomeLoss
Net income6 months2013-10-01 to 2014-03-31$75.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-01-01 to 2014-03-31$0.59us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2013-10-01 to 2014-03-31$1.08us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-01-01 to 2014-03-31$0.61us-gaap:EarningsPerShareBasic
Basic EPS6 months2013-10-01 to 2014-03-31$1.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-01-01 to 2014-03-3169,307,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2013-10-01 to 2014-03-3169,538,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2013-10-01 to 2014-03-31$76.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2013-10-01 to 2014-03-31$9.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2013-10-01 to 2014-03-31$6.1mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2013-10-01 to 2014-03-31$34.7mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-03-31$131.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-03-31$535.5mus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$897.0mus-gaap:Assets
Current liabilitiesAt period end2014-03-31$256.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-03-31$325.3mus-gaap:Liabilities
Long-term debtAt period end2014-03-31$1.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2014-03-31$158.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-03-31$571.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-14-036769. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.